Obalon Therapeutics, Inc. (OBLN) Stock Skyrockets after Class-Action Lawsuit Controversy Dies Down
Obalon Therapeutics, Inc. (OBLN) stock prices skyrocketed by 30.45% as of the market closing on May 10th, 2021, bringing the price per share up to USD$2.87 at the end of the trading day. OBLN’s Merger with ReShape November 10th, 2020 saw the pioneer of the FDA-approved balloon system for obesity treatment announce that it had […]
Obalon Therapeutics, Inc. (OBLN) Stock Undergoes Volatility as Pandemic Regulations Relaxed
Obalon Therapeutics, Inc. (OBLN) stock prices were down by 15.13% as of the market closing on May 6th, 2021, bringing the price per share down to USD$2.02. Subsequent pre-market fluctuations have seen the stock rally by 9.90%, bringing it up to UD$2.22. Merger with ReShape Lifesciences The pioneer of the FDA-approved balloon system of treatment […]
